Two new eremophilenolides, 6,810-trihydroxyeremophil-7(11)-en-12,8-olide (1) and 3-acetoxy-8-hydroxy-6-methoxyeremophila-7(11),9-dien-12,8olide (2) along with twenty-nine other compounds were obtained from the methanolic extracts of the aerial parts and rhizomes of Farfugium japonicum (L.) Kitam. var. formosanum (Hayata) Kitam. (Compositae = Asteraceae). The structures of the isolated compounds were characterized and identified by spectral techniques. Compounds 5, 6, 10, 12-24, 29, and 30, were reported for the first time from this genus. Cytotoxicity and anti-inflammatory activity of the isolated compounds were evaluated. Compounds 3 and 16 possessed moderate cytotoxicity against human breast cancer cell line (MCF 7). Compounds 3, 16, 25 and 26 exhibited moderate cytotoxicity against hepatoma cells (Hep G2 and Hep 3B). With respect to the anti-inflammatory activity, compounds 15 and 16 (each 10 µg/mL) inhibited superoxide anion generation by human neutrophils in response to fMLP/CB by 92.0% and 87.3%, respectively.
The genus Farfugium (Compositae = Asteraceae) consists of three species distributed throughout eastern Asia. In Taiwan, one species is represented by two varieties; Farfugium japonicum (L.) Kitam. var. formosanum (Hayata) Kitam and F. japonicum (L.) Kitam. var. japonicum. F. japonicum var. formosanum is indigenous to Taiwan and distributed at high latitude (100-2,000 m over sea-level) [1] . The plant has been utilized in Asia to treat several health disorders especially inflammatory diseases. The whole plant has been used for the treatment of influenza, the roots for pharyngitis, the ground part for curing wounds, the fresh leaves for furuncles, and the petioles for cystitis [2, 3] . The interesting biological activities and the scarcity of scientific research on F. japonicum var. formosanum have encouraged us to study the active secondary metabolites of this plant. Two new eremophilenolides, along with twenty-nine known compounds were isolated and characterized.
Sixteen compounds were obtained from the methanolic extract of the rhizomes, including nine sesquiterpenoids: 6,810trihydroxyeremophil-7(11)-en-12,8-olide (1), 3-acetoxy-8hydroxy-6-methoxyeremophila-7(11),9-dien-12,8-olide (2) , farformolide B (4) [4] , 8,10-dihydroxy-6-methoxyeremophil-7(11)en-12,8-olide (5) [5] , 8-hydroxy-6-methoxyeremophila-7(11),9dien-12,8-olide (6) [5] , 6-ethoxyfranoeremophilan-10-ol (3) [6] , 6-methoxyfuranoeremophilan-10-ol (7) [7] , furanoeremophilan-6,10-diol (8) [7] and farfugin A (9) [8] ; four benzenoids: caffeic acid (15) [9] , methyl caffeate (16) [10] , p-hydroxy-benzaldehyde (18) [11] and 4-hydroxyacetophenone (19) [12] ; one phenolic: petasiphenol (21) [13] ; two steroids as a mixture of -sitosterol (27) [14] and stigmasterol (28) [14] . Twenty compounds were obtained from the methanolic extract of the aerial part, including three sesquiterpenoids: farformolide B (4) [4] , 8,10-dihydroxy-6methoxyeremophil-7(11)-en-12,8-olide (5) [5] and liguhodgsonal (10) [15] ; three diterpenes: phytol (11) [16] , 3-methoxy-3,7,11,15tetramethylhexadecan-1,2-diol (12) [17] and phytan-1,2,3-triol (13) [18] ; one quinol: 4-acetonyl-3,5-dimethoxy-p-quinol (14) [19] ; three benzenoids: methyl caffeate (16) [10] , methyl 4-hydroxy-3methoxycinnamate (17) [20] and p-hydroxybenzoic acid (20) [9] ; five triterpenes: friedelin (22) [14] , friedelan-3-ol (23) [21] , ursolic acid (24) [22] , -amyrin (25) [23] and -amyrin acetate (26) (which was prepared by acetylation of -amyrin) [24] ; four steroids: a mixture of 27 and 28 [14] along with a mixture of -sitosteryl-3-O--D-glucoside (29) [14] and stigmasteryl-3-O--Dglucoside (30) [14] ; one fatty acid: palmitic acid (31) [25] . Among the isolates, 1 and 2 are new compounds. Compounds 5, 6, 10, 12-24, 29, and 30 were isolated from the genus for the first time ( Figure 1) . The cytotoxicity and the anti-inflammatory activities of the isolated compounds were evaluated. The IR spectra of 1, 2, 4, and 5 were similar showing absorptions for a -unsaturated -lactone carbonyl moiety (1767, 1765, 1760, 1736 cm -1 , respectively) [4, 5, 26] . The 1 H and 13 C NMR spectra of 1 and 2 were similar to the spectra of eremophilenolides derivatives (4 and 5) implying that 1 and 2 possessed the same skeleton ( Table  1 , 2) [4, 5] . The FAB mass spectrum of 1 showed a molecular ion at m/z 282 [M] + , corresponding to a molecular formula, C 15 H 22 O 5 . In comparison with the NMR data of 5, one methoxy group signal was missing in the 1 H NMR of 1 and the 13 C NMR spectra showed signals at  80.5, 103.6 and 75.1 indicating the presence of three hydroxy groups in 1. The HMBC correlations of H-14 → C-5 ( 2 J), C-4, 6, 10 ( 3 J); H-15 → C-4 ( 2 J), C-3, 5 ( 3 J); H-13 → C-11 ( 2 J), C-7, 12 ( 3 J); H-9  → C-8, 10 ( 2 J); H-9  → C-8, 10 ( 2 J), C5, 7 ( 3 J) indicated the positions of hydroxy groups at C-6, C-8 and C-10. Homoallylic spin-coupling (J = 1.0-1.5 Hz) between H-6and CH 3 -13 is used to differentiate between 8-hydroxy, and 8-hydroxyeremophilenolides [27] [28] [29] . The homoallylic spincoupling is observed in 8-hydroxy but it is absent in 8-hydroxy eremophilenolides. Based on this fact, it was obvious that 1 has 8-hydroxy group due to the absence of coupling constant between H-6and CH 3 -13 [5] . The NOESY correlations ( Figure 2 ) proved a cis junction between rings A and B (Figure 1 ). The 1,3-diaxial correlation between H-1 ax , H-3 ax , CH 3 -14 were confirmed by NOESY. Therefore, compound 1 was identified as 6,810trihydroxyeremophil-7(11)-en-12,8-olide.
The molecular formula of 2 was deduced to be C 18 1*: The 13 C NMR and DEPT spectra indicated the presence of seven quaternary carbon atoms, four methines, two methylenes, and five methyl groups. In addition, the 1 H NMR spectra showed homoallylic spin-coupling between CH 3 -13 ( 1.98, d, J = 1.4 Hz) and H-6 (4.16, d, J = 1.4 Hz), implying that 8-hydroxy is oriented [27, 28] . The stereo orientation of the other chiral centers in 2 was proposed based on the obtained NOESY correlations (Fig.  3 ). The 1,3-diaxial correlation was observed between H-1 ax ( 2.48) and CH 3 -14 ( 1.11) indicating the -orientation of CH 3 -14. Thus, compound 2 was elucidated as 3-acetoxy-8-hydroxy-6methoxyeremophila-7(11),9-dien-12,8-olide.
The isolated compounds 3, 7 and 8 were unstable in air or chloroform. In our study we found that 7 can be easily oxidized to 1. Moreover, phytol (11) was unstable and easily oxidized to 13 which can be further converted to 12 (upon the use of MeOH as a solvent).
Compounds 1-31 were screened for their cytotoxicity (Table 3) and anti-inflammatory activity (Table 4 ). 
Experimental
General: UV spectra were measured on a Jasco V-530 UV/VIS spectrophotometer (JASCO Inc., Tokyo, Japan). IR spectra were recorded on a Mattson Genesis II TM FT-IR spectrophotometer (Mattson Instruments, Madison, WI, USA). The optical rotations were taken on a Jasco-P-1020 polarimeter (cell length 10 mm) (JASCO Inc., Tokyo, Japan Extraction and isolation:The fresh aerial parts (8.0 kg) were extracted five times by MeOH at room temperature to obtain a crude extract (350 g). The crude extract was then partitioned with EtOAc and water (1:1, v/v), and an EtOAc soluble portion (49.8 g) was obtained. The EtOAc soluble portion was divided into nine crude fractions (frs.) by column chromatography over silica gel (230~400 mesh, 7 × 25 cm) with gradient elution of n-hexane→EtOAc. Fraction 2 was separated over a silica gel column (230~400 mesh, 3.5 × 20.0 cm) eluted with n-hexane→EtOAc yielding three fractions. Fraction 2-1 was separated over a silica gel column (230~400 mesh, 2.5 × 25.5 cm) eluted with n-hexane→EtOAc yielding two fractions. Fr. 2-1-1 was purified over a silica gel column (230~400 mesh, 2.5 × 25.5 cm) eluted with n-hexane→EtOAc yielding compound 5 [5] (87.2 mg, CHCl 3 -MeOH, 8:1, R f : 0.3) and 11 [14] (89.8 mg, n-hexane-EtOAc, 10:1, R f : 0.4). Compound 5 was re-crystalized from EtOAc. From fr. 2-1-2, compound 23 [15] (5.0 mg, n-hexane-EtOAc, 10:1, R f : 0.65) and 25 [16] (142.6 mg, n-hexane-EtOAc, 8:1, R f : 0.4) were obtained through purifying over a silica gel column (230~400 mesh, 2.5 × 25.5 cm) eluted with n-hexane→EtOAc. Fraction 2-2 was subjected to silica gel column (230~400 mesh, 3.5 × 15 cm) eluted with nhexane-EtOAc (1:5, v/v) and then washed out with MeOH, which afforded compound 27 [17] and 28 [17] as a mixture (50.1 mg, nhexane-EtOAc, 6:1, R f : 0.3). Fraction 3 was isolated by column chromatography (silica gel, 230~400 mesh, 4 × 22 cm) eluted with n-hexane→EtOAc to obtain 20 fractions. Needle crystals were detected in the chromatographic separation of fraction 3 which were re-crystalized from EtOAc to yield compound 22 [17] (24.9 mg, nhexane-EtOAc, 25:1, R f : 0.45). Fraction 3-11 was dissolved in MeOH and filtered to yield MeOH soluble fraction (fr. 3-11-M) and MeOH insoluble fraction. Fr. 3-11-M was isolated into 5 fractions using Sephadex LH-20 (2 × 18 cm) which was eluted with MeOH. A white precipitate was detected in the chromatographic fractionation of fraction 3-11-M which was washed with EtOAc yielding compound 24 [21] . Fr. 3-11-M-4 was purified using HPLC equipped with Cosmosil column (20 × 250 mm) eluted with n-hexane-EtOAc = 7:3 (flow rate 3 mL/min) resulting in the separation of compound 10 [18] (R t : 32.36 min, 7 mg). Fr. 3-11-M-5 was subjected to silica gel column chromatography (230~400 mesh, 1.5 × 20 cm, n-hexane→EtOAc) leading to the separation of compounds 4 [4] (42.1 mg, n-hexane-EtOAc, 5:1, R f : 0.3, recrystallized from EtOAc), 17 [19] (6.7 mg, n-hexane-EtOAc, 10:1, R f : 0.45) and 20 [20] (1.3 mg). (14.4 mg, n-hexane-EtOAc, 3:1, R f : 0.3). Fr. 5 was subjected to silica gel column chromatography (230~400 mesh, 2.5 × 20 cm, eluted with CHCl 3 →MeOH) leading to the isolation of compound 16 [22] (18.6 mg, n-hexane-EtOAc, 2:1, R f : 0.2) which was re-crystallized from MeOH. Fr. 6 was separated into three fractions by activated charcoal. Fr. 6-2 was purified using silica gel column (230~400 mesh, 2.5 × 20 cm, eluted with n-hexane→EtOAc) to afford a mixture of 29 [17] and 30 [17] (30.7 mg, n-hexane-EtOAc, 6:1, R f : 0.3). Fr. 7 was purified with preparative TLC (using 100% EtOAc as a mobile phase) rendering compound 14 [23] (1.9 mg, 100% EtOAc, R f : 0.6).
The rhizomes of F. japonicum (8.0 kg) were extracted with MeOH and partitioned with EtOAc similar to the procedures implied in the extraction of aerial parts. The EtOAc soluble layer (30 g) was chromatographed on Sephadex LH-20 (4 × 36 cm) using MeOH as the eluent, and divided into seven crude fractions (frs.). Fr. 4 was separated into ten fractions using silica gel column chromatography (230~400 mesh, 5 × 23 cm) and eluted with n-hexane→EtOAc. A white precipitate was detected in the chromatographic separation of fraction 4 which was washed with MeOH leading to the isolation of compounds 27 [17] and 28 [17] as a mixture (247.2 mg). Fr. 4-1 was subjected to silica gel column chromatography (230~400 mesh, 3 × 30 cm, n-hexane→EtOAc) to yield compounds 9 [4] (53.5 mg, 100% n-hexane, R f : 0.9, re-crystallized from n-hexane), 7 [13] (2.52 g, n-hexane-EtOAc, 8:1, R f : 0.5), 3 (84.1 mg, n-hexane-EtOAc, 5:1, R f : 0.6), and 8 [13] (62.9 mg, n-hexane-EtOAc, 3:1, R f : 0.3). A white precipitate was detected in the chromatographic fractionation of fraction 4-1 which was washed with n-hexane yielding 4 [4] (138.5 mg). Fr. 4-4 was further subjected to column chromatography on silica gel (230~400 mesh, 3 × 21.5 cm) and eluted with n-hexane→EtOAc to obtain compounds 5 (39.7 mg) and 6 [5] (4.4 mg, 100% EtOAc, R f : 0.4). Fr. 4-10 was fractioned into nine fractions by column chromatography (silica gel, 230~400 mesh, 2.5 × 20.5 cm, CHCl 3 →MeOH). Fr. 4-10-5 was purified by preparative TLC (using CHCl 3 -MeOH, 15:1 as the mobile phase) to yield compound 2 (10.3 mg, CHCl 3 -MeOH, 15:1, R f : 0.4). Fr. 5 was separated on a silica gel column (230~400 mesh, 2.5 × 26.5 cm) using n-hexane→EtOAc as the eluent to give ten fractions. Fr. 5-2 was recrystallized with MeOH offering compound 16 [22] (393.7 mg, n-hexane-EtOAc, 2:1, R f : 0.2). Fr. 5-5 was purified by preparative TLC (using CHCl 3 -MeOH, 8:1 as the mobile phase) to yield 15 [20] (46.9 mg, CHCl 3 -MeOH, 8:1, R f : 0.3). Compounds 21 [25] (52.4 mg, CHCl 3 -MeOH, 10:1, R f : 0.25), 18 [26] (2.5 mg) and 19 [27] (1.1 mg) were isolated from fr. 5-9 with silica gel column (230~400 mesh, 2.5 × 27 cm) using CHCl 3 →MeOH as the eluent.
Compound 1 (16.9 mg, n-hexane-EtOAc, 1:1, R f : 0.25) was separated using silica gel column chromatography (230~400 mesh, 2.5 × 16 cm, n-hexane→EtOAc) as 1 is the decomposition product of 7. Compounds 12 [28] (9.0 mg, R t : 30.77 min) and 13 [29] (7.0 mg, R t : 48.65 min) were separated using HPLC [Cosmosil column 20 × 150, n-hexane-EtOAc 50:50; flow rate: 3 mL/min] as these compounds are also the decomposition products of 11. Compound 26 [30] was prepared by acetylation of 25 [16] . Compound 25 (53.6 mg) was reacted with excess acetic anhydride in dry pyridine for 24 h at room temperature. The products were purified with silica gel column chromatography to yield 26 (58.7 mg). -7(11)-en-12,8- 
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Anti-inflammetory activity
Preparation of Human Neutrophils: Blood was taken from healthy human donors (20-35 years old) by venipuncture using a protocol approved by the institutional review board at Chang Gung Memorial Hospital. Neutrophils were isolated utilizing standard protocol.
Measurement of Superoxide Generation: Superoxide generation inhibition was measured by the reduction of ferricytochrome c. [31, 32] . Neutrophils in 0.5 mg/mL ferricytochrome c and 1 mM Ca 2+ were equilibrated at 37 °C for 2 min and then incubated with tested compounds for 5 min. Cells were activated with formyl-methionyl-leucyl-phenylalanice (FMLP, 100 nM)/cytochalasin B (CB, 1 µg/mL) or phorbol 12-myristate 13-acetate (PMA) for 10 min. The absorbance was continuously monitored at 550 nm in a doublebeam, six-cell positioned spectrophotometer with constant stirring (Hitachi U-3010, Hitachi Inc., Tokyo, Japan). Calculations were based on differences in absorbance with and without SOD (100 U/mL) divided by the extinction coefficient for the reduction of ferricytochrome c (ε = 21.1/mM/10 mm).
Cytotoxicity assays
Cancer cell lines (MDA-MB-231, MCF 7, Hep G2, Hep 3B) were obtained from the American Type Culture Collection. All cell lines were cultured on RPMI-1640 medium supplemented with 10% (v/v) FBS (fetal bovine serum), 100 U/mL penicillin and 100 µg/mL streptomycin at 37°C in a humidified atmosphere of 5% CO 2 and 95% air. Cell viability was measured by MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) colorimetric method [33] . In brief, freshly trypsinized cell suspensions were seeded in 96-well microtiter plates at densities of 5,000-10,000 cells per well and the test compounds were added from DMSO stock solutions (the final concentration of DMSO in culture medium was 0.2%). After 3 days in culture, the attached cells were incubated with MTT (0.5 µg/mL, 4 h) and subsequently solubilized in DMSO. The absorbance was measured at 550 nm using a microplate reader. The calculated IC 50 was the concentration of the tested agent that reduced cell growth by 50% under the experimental conditions. The results represented the mean of three separate experiments, each performed in triplicate.
